IL110289A - Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis - Google Patents

Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis

Info

Publication number
IL110289A
IL110289A IL110289A IL11028994A IL110289A IL 110289 A IL110289 A IL 110289A IL 110289 A IL110289 A IL 110289A IL 11028994 A IL11028994 A IL 11028994A IL 110289 A IL110289 A IL 110289A
Authority
IL
Israel
Prior art keywords
idx
iodo
deoxydoxorubicin
amyloidosis
patient
Prior art date
Application number
IL110289A
Other languages
English (en)
Hebrew (he)
Other versions
IL110289A0 (en
Original Assignee
Policlinico San Matteo Istitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT93MI001800A external-priority patent/IT1265055B1/it
Priority claimed from ITMI940621A external-priority patent/IT1274032B/it
Application filed by Policlinico San Matteo Istitut filed Critical Policlinico San Matteo Istitut
Publication of IL110289A0 publication Critical patent/IL110289A0/xx
Publication of IL110289A publication Critical patent/IL110289A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
IL110289A 1993-08-06 1994-07-12 Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis IL110289A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001800A IT1265055B1 (it) 1993-08-06 1993-08-06 Uso della 4'-desossi-4'-iododoxorubicina per il trattamento della al amiloidosi
ITMI940621A IT1274032B (it) 1994-03-31 1994-03-31 Uso della 4'-desossi-4'-idodoxorubicina per il trattamento della al amiloidosi nella malattia di alzheimer

Publications (2)

Publication Number Publication Date
IL110289A0 IL110289A0 (en) 1994-10-21
IL110289A true IL110289A (en) 1998-01-04

Family

ID=26331037

Family Applications (1)

Application Number Title Priority Date Filing Date
IL110289A IL110289A (en) 1993-08-06 1994-07-12 Pharmaceutical preparations containing 4-iodo-4-deoxydoxorubicin for the treatment of amyloidosis

Country Status (20)

Country Link
US (1) US5637572A (hu)
EP (1) EP0663832B1 (hu)
JP (1) JPH08505401A (hu)
KR (1) KR100270465B1 (hu)
AT (1) ATE200624T1 (hu)
AU (1) AU687432B2 (hu)
CA (1) CA2142349A1 (hu)
DE (1) DE69427116T2 (hu)
DK (1) DK0663832T3 (hu)
ES (1) ES2157984T3 (hu)
GR (1) GR3036221T3 (hu)
HK (1) HK1011280A1 (hu)
HU (1) HU217546B (hu)
IL (1) IL110289A (hu)
MY (1) MY111755A (hu)
PL (1) PL180000B1 (hu)
PT (1) PT663832E (hu)
RU (1) RU2155589C2 (hu)
UA (1) UA29461C2 (hu)
WO (1) WO1995004538A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9418260D0 (en) * 1994-09-09 1994-10-26 Erba Carlo Spa Anthracycline derivatives
GB9516349D0 (en) * 1995-08-09 1995-10-11 Pharmacia Spa Aza-anthracyclinone derivatives
WO1997026919A2 (en) * 1996-01-24 1997-07-31 Warner-Lambert Company Method of imaging amyloid deposits
GB9805082D0 (en) 1998-03-10 1998-05-06 Pharmacia & Upjohn Spa Heterocyclyl anthracyclinone derivatives
GB9805080D0 (en) 1998-03-10 1998-05-06 Pharmacia & Upjohn Spa Amino anthracyclinone derivatives
PL237739B1 (pl) 2018-06-06 2021-05-17 Univ Gdanski Genisteina do zastosowania do leczenia choroby Alzheimera

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438105A (en) * 1982-04-19 1984-03-20 Farmaitalia Carlo Erba S.P.A 4'-Iododerivatives of anthracycline glycosides
JPH0725786A (ja) * 1990-05-16 1995-01-27 Univ Rockefeller アルツハイマー病を伴うアミロイドーシスの治療
JP4142304B2 (ja) * 2001-10-22 2008-09-03 株式会社安川電機 アーク溶接用ロボット

Also Published As

Publication number Publication date
EP0663832A1 (en) 1995-07-26
US5637572A (en) 1997-06-10
AU687432B2 (en) 1998-02-26
RU2155589C2 (ru) 2000-09-10
EP0663832B1 (en) 2001-04-18
WO1995004538A1 (en) 1995-02-16
UA29461C2 (uk) 2000-11-15
PL308245A1 (en) 1995-07-24
DE69427116T2 (de) 2001-08-02
ES2157984T3 (es) 2001-09-01
MY111755A (en) 2000-12-30
IL110289A0 (en) 1994-10-21
AU7460894A (en) 1995-02-28
PT663832E (pt) 2001-09-28
DK0663832T3 (da) 2001-05-07
DE69427116D1 (de) 2001-05-23
HK1011280A1 (en) 1999-07-09
JPH08505401A (ja) 1996-06-11
HU9500375D0 (en) 1995-06-28
HU217546B (hu) 2000-02-28
KR100270465B1 (ko) 2000-11-01
PL180000B1 (en) 2000-11-30
CA2142349A1 (en) 1995-02-16
GR3036221T3 (en) 2001-10-31
HUT70521A (en) 1995-10-30
ATE200624T1 (de) 2001-05-15

Similar Documents

Publication Publication Date Title
Meltzer et al. Cryoglobulinemia—a clinical and laboratory study: II. Cryoglobulins with rheumatoid factor activity
Gianni et al. New drug therapy of amyloidoses: resorption of AL-type deposits with 4'-iodo-4'-deoxydoxorubicin
Behr et al. Reduction of renal uptake of monoclonal antibody fragments by amino acid infusion
Floege et al. Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-β2-microglobulin
KR100268660B1 (ko) 간질성방광염의치료및예방을위한제약학적조성물
Bateman et al. Fatal complications of intensive antibiotic therapy in patients with neoplastic disease
US20030190319A1 (en) Antibodies specific for CD44v6
MXPA03010035A (es) Tratamiento y diagnostico de enfermedades mediadas por macrofagos.
Moolten et al. Antitumor effects of antibody-diphtheria toxin conjugates: Use of hapten-coated tumor cells as an antigenic target
JPH07505905A (ja) 修飾ｃ反応性タンパク質を使用する癌の治療方法
Rifai et al. Complement activation in experimental IgA nephropathy: an antigen-mediated process
US5637572A (en) Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
Vaidyanathan et al. Improved xenograft targeting of tumor-specific anti-epidermal growth factor receptor variant III antibody labeled using N-succinimidyl 4-guanidinomethyl-3-iodobenzoate
JPH10506398A (ja) 炎症性疾患治療用コンジュゲート
Donald et al. CURRENT CONCEPTS OE CUTANEOUS PORPHYRIA AND ITS TREATMENT WITH PARTICULAR REEERENCE TO THE USE OF SODIUM CALCIUMEDETATE
US6028060A (en) Treatment of chronic inflammatory diseases with CM101/GBS toxin
Scott Iron-sorbitol–Citrate in Pregnancy Anaemia
AU6306598A (en) Peptides for the treatment of systemic lupus erythematosus
Cunningham et al. Development of a radioimmunoassay for neurone specific enolase (NSE) and its application in the study of patients receiving intra hepatic arterial streptozotocin and floxuridine
Boström et al. Case of chondrosarcoma with pulmonary and skeletal metastases after hemipelvectomy, successfully treated with 35S-sulfate
TWI846107B (zh) 幾丁質酶-3-類似蛋白-1中和抗體及其用途
Robbins et al. Radiation–Related Renal Damage
Rokosova et al. Biosynthesis of aortic collagen and glycosaminoglycan following immunological injury
EP0406363B1 (en) Method to diagnose amyloidoses specifically and substance therefor
Shafiroff et al. Subcutaneous administration of combined fat emulsion with hyaluronidase.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired